Australia markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
106.97-1.65 (-1.52%)
At close: 04:00PM EDT
107.30 +0.33 (+0.31%)
After hours: 07:32PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
1,506,310
881,482
591,448
1,057,769
-
Other short-term investments
120,000
0
0
1,075,000
-
Total cash
1,626,310
881,482
591,448
2,132,769
-
Net receivables
705,794
651,493
563,360
396,490
-
Inventory
597,039
714,061
1,072,721
95,396
-
Other current assets
149,302
91,135
48,912
38,257
-
Total current assets
3,435,428
2,606,140
2,611,334
2,839,568
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
368,337
409,023
428,794
324,692
-
Accumulated depreciation
-133,351
-107,647
-85,371
-67,588
-
Net property, plant and equipment
234,986
301,376
343,423
257,104
-
Goodwill
1,753,130
1,692,662
1,827,609
958,303
-
Intangible assets
5,418,039
5,794,437
7,152,328
2,195,051
-
Other long-term assets
67,464
55,139
40,813
25,721
-
Total non-current assets
7,957,931
8,229,115
9,687,305
3,696,333
-
Total assets
11,393,359
10,835,255
12,298,639
6,535,901
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
604,954
31,000
31,000
246,322
-
Accounts payable
102,750
90,758
100,298
26,945
-
Taxes payable
35,074
7,717
9,608
25,200
-
Accrued liabilities
632,142
617,910
457,438
213,681
-
Deferred revenues
0
463
2,093
2,546
-
Other current liabilities
681
-
18,419
3,625
1,037
Total current liabilities
1,536,692
933,193
809,303
653,745
-
Non-current liabilities
Long-term debt
5,107,988
5,693,341
6,018,943
1,848,516
-
Deferred tax liabilities
847,706
944,337
1,300,541
130,397
-
Deferred revenues
-
0
463
2,315
4,861
Other long-term liabilities
104,751
106,812
116,998
101,148
-
Total non-current liabilities
6,119,670
6,816,328
7,524,145
2,222,411
-
Total liabilities
7,656,362
7,749,521
8,333,448
2,876,156
-
Stockholders' equity
Common stock
61
61
61
61
-
Retained earnings
878,656
733,586
830,226
1,159,894
-
Accumulated other comprehensive income
-842,147
-1,125,509
-400,360
-134,352
-
Total stockholders' equity
3,736,997
3,085,734
3,965,191
3,659,745
-
Total liabilities and stockholders' equity
11,393,359
10,835,255
12,298,639
6,535,901
-